srch

ACS Med Chem Lett. @ACSMedChemLett. ACS International Journal for Urgent Research in Medicinal Chemistry. Journal Editor: Dennis Liotta.

2 dager siden · A series of brigatinib derivatives were designed and synthesized as new potent and selective EGFRT790M/C797S inhibitors. One of the most potent and selective compounds 18k strongly suppressed the EGFRL858R/T790M/C797S and EGFR19Del/T790M/C797S kinases with IC50 values of 0.7 and 3.6 nM, respectively, which were over 54-fold more potent than the …

ACS Med Chem Lett Articles from this journal are generally available in PMC after a 12-month delay (embargo); however, the delay may vary at the discretion of the publisher. ACS Medicinal Chemistry Letters

Nov 10, 2015 · New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science. ACS Medicinal Chemistry Letters, ACS Pharmacology & Translational Science, and Journal of Medicinal Chemistry welcome submissions to this joint Virtual Special Issue. Submission deadline: July 31, 2022. Read the Editorial to learn more

ACS Medicinal Chemistry Letters ; 2020/2021, -, 4.345 ; 2019, -, 3.975 ; 2018, -, 3.737 ; 2017, -, 3.794 ...

The Psychedelic Renaissance: Addressing Potential Adverse Effects in a Therapeutic Setting. Robert B. Kargbo*. ACS Medicinal Chemistry Letters 2021, 12, 12, 1874-1875 (Patent Highlight) Publication Date (Web): November 8, 2021. Full text.

ACS Med. Chem. Lett. ... ACS Medicinal Chemistry Letters, Articles ASAP (Expression of Concern) Publication Date (Web): October 12, 2021. Full text; PDF; September 29, 2021. Design and Evaluation of Bispidine-Based SARS-CoV-2 Main …

The impact score (IS) 2020 of ACS Medicinal Chemistry Letters is 3.68, which is computed in 2021 as per its definition. ACS Medicinal Chemistry ...

10.11.2015 · New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science. ACS Medicinal Chemistry Letters, ACS Pharmacology & Translational Science, and Journal of Medicinal Chemistry welcome submissions to this joint Virtual Special Issue. Submission deadline: July 31, 2022. Read the Editorial to learn more

ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies ...

ACS Medicinal Chemistry Letters , ACS Pharmacology & Translational Science , and Journal of Medicinal Chemistry welcome submissions to this joint Virtual ...

14.10.2021 · STEP 1: Login with ACS ID Logged in Success. Click to create an ACS ID. STEP 2: Login with Mendeley Logged in Success. Create a Mendeley account. Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

ACS Med Chem Lett Articles from this journal are generally available in PMC after a 12-month delay (embargo); however, the delay may vary at the discretion of the publisher. ACS Medicinal Chemistry Letters

Scope ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules.

ACS Medicinal Chemistry Letters is an online publication that publishes original research in the form of Letters, Notes, and Technology Notes. The journal also ...

ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas …

Mar 11, 2021 · ACS Medicinal Chemistry Letters 2021, 12, 3, 309 (In This Issue) Publication Date (Web): March 11, 2021 Full text PDF Patent Highlights 1-Pyrazolyl-5,6-Disubstituted Indazole Derivatives as LRRK2 Inhibitors for Treating Parkinson’s Disease Ram W. Sabnis* ACS Medicinal Chemistry Letters 2021, 12, 3, 310-311 (Patent Highlight)

Logo of acsmedlett. ACS Med Chem Lett. Articles from this journal are generally available in PMC after a 12-month delay (embargo); however, the delay may ...

ACS Med. Chem. Lett. All Publications/Website. OR SEARCH CITATIONS ... Authors who submit Letters are no longer required to use one of the templates available below. Use of the template will ensure proper formatting and will facilitate the placement of graphics in the manuscript.

ACS Medicinal Chemistry Letters is a monthly peer-reviewed scientific journal covering medicinal chemistry. It was established in 2009 and is published by ...

Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened. ACS Med Chem Lett. 2011 Dec 21;3 (2):106-11. doi: 10.1021/ml2002423. eCollection 2012 Feb 9.

06.12.2021 · ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules.